Studies began to unveil its efficacy in promoting healing and tissue repair in various other systems of the body, including musculoskeletal, cardiovascular, and nervous systems
Yet, adoption of this technology in clinical practise is still in its infancy, as several open issues must be addressed, including piezoelectric property measurement, control of the ultrasound dose delivered in vitro, modelling and measurement of the piezo effects, knowledge of triggered bioeffects, biocompatibility studies, therapy targeting, and control of the ultrasound dose delivered in vivo
The GIP receptor plays an important role in regulating insulin and appetite, providing an additional mechanism for improved blood sugar control and appetite suppression
The challenge here is accessibility